Dipeptidyl Peptidase-4 Inhibitors in T2DM Linked to IBD

Share this content:
Dipeptidyl Peptidase-4 Inhibitors in T2DM Linked to IBD
Dipeptidyl Peptidase-4 Inhibitors in T2DM Linked to IBD

THURSDAY, March 22, 2018 (HealthDay News) -- Dipeptidyl peptidase-4 (DPP-4) inhibitors are associated with increased risk of inflammatory bowel disease among patients with type 2 diabetes, according to a study published online March 21 in The BMJ.

Devin Abrahami, from the Jewish General Hospital in Montreal, and colleagues conducted a population-based cohort study to examine whether use of DPP-4 inhibitors is associated with the incidence of inflammatory bowel disease in patients with type 2 diabetes. Participants included 141,170 patients starting antidiabetic drugs between Jan. 1, 2007, and Dec. 31, 2016, with follow-up until June 30, 2017.

The researchers identified 208 incident inflammatory bowel disease events during 552,413 person-years of follow-up (crude incidence rate, 37.7 per 100,000 person-years; 95 percent confidence interval, 32.7 to 43.1). Use of DPP-4 inhibitors correlated with elevated risk of inflammatory bowel disease (53.4 versus 34.5 per 100,000 person-years; hazard ratio, 1.75; 95 percent confidence interval, 1.22 to 2.49). With longer duration of use there was an increase in hazard ratios, reaching a peak after three to four years of use (hazard ratio, 2.90; 95 percent confidence interval, 1.31 to 6.41) and decreasing after more than four years of use (hazard ratio, 1.45; 95 percent confidence interval, 0.44 to 4.76). There was a similar pattern with time since initiation of DPP-4 inhibitors. In several sensitivity analyses, these findings remained consistent.

"In this first population-based study, the use of DPP-4 inhibitors was associated with an increased risk of inflammatory bowel disease," the authors write. "Although these findings need to be replicated, physicians should be aware of this possible association."

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Many Americans May Have Prediabetes and Not Know It

CDC: Many Americans May Have Prediabetes and Not ...

AMA, CDC launch a campaign to raise awareness about prediabetes

Low-Carbohydrate Diets Linked to Increase in Calories Burned

Low-Carbohydrate Diets Linked to Increase in Calories Burned

Total energy expenditure is greater for those on a low- or moderate-carb diet during weight-loss maintenance

Many Patients Do Not Engage Health Care Provider During MS Relapse

Many Patients Do Not Engage Health Care Provider ...

Only half of patients reported always engaging health care providers

is free, fast, and customized just for you!




Already a member?

Sign In Now »